Bioactive dressing based on bacterial cellulose modified with carboxymethyl groups (mBC) was successfully prepared and studied. The surface of mBC was activated using carbodiimide chemistry and decorated with alginate/hydroxypropyl cellulose submicroparticles containing dexamethasone phosphate (DEX-P). Prior to their deposition particles were coated with chitosan in order to facilitate their binding to mBC, and to increase the control over the release process. The detailed physicochemical characterization of the particles and the bioactive dressing was performed, including the determination of the particles' size and size distribution, DEX-P encapsulation efficiency and loading, particles' distribution on the surface of the mBC membrane, as well as DEX-P release profiles from free and mBC-bound particles. Finally, the preliminary cytotoxicity studies were performed. The fabricated bioactive material releases DEX-P in a controlled manner for as long as 25 h. Biological tests in vitro indicated that the dexamethasone-containing submicroparticles are not toxic toward fibroblasts, while effectively inhibiting their proliferation. The prepared bioactive dressing may be applied in the treatment of the post-operative wounds in the therapy of keloids and in other fibrosis-related therapies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.